journal cover

Renal safety of initial combination versus single DMARD therapy in patients with early rheumatoid arthritis: an 11-year experience from the FIN-RACo Trial

Clinical and Experimental Rheumatology

Mar 30, 2010

K L KarstilaFIN-RACo Trial Group

PMID: 20346242

Download from

PubMed

Abstract

To evaluate the renal safety of traditional disease-modifying antirheumatic drugs (DMARDs) in early rheumatoid arthritis (RA). One hundred and ninety-five DMARD-naïve patients with recent-onset RA were randomised to receive combination DMARD therapy (n=97) starting with sulfasalazine, m...read more

Mentioned in this Paper

Urinalysis
Antirheumatic Drugs, Disease-Modifying
Predonine
Hydroxychloroquine
Plaquenil
Sulfasalazin medac
Proteinuria
Prednisolone
Polychemotherapy
Kidney
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Feeds With Similar Papers

Inflammatory Bowel Disease

Inflammatory bowel diseases (IBD), Crohn’s disease and ulcerative colitis, arise due to chronic inflammation of the gastrointestinal tract. Here is the latest research.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

© 2020 Meta ULC. All rights reserved

Renal safety of initial combination versus single DMARD therapy in patients with early rheumatoid arthritis: an 11-year experience from the FIN-RACo Trial

Clinical and Experimental Rheumatology

Mar 30, 2010

K L KarstilaFIN-RACo Trial Group

PMID: 20346242

DOI:

Abstract

To evaluate the renal safety of traditional disease-modifying antirheumatic drugs (DMARDs) in early rheumatoid arthritis (RA). One hundred and ninety-five DMARD-naïve patients with recent-onset RA were randomised to receive combination DMARD therapy (n=97) starting with sulfasalazine, m...read more

Mentioned in this Paper

Urinalysis
Antirheumatic Drugs, Disease-Modifying
Predonine
Hydroxychloroquine
Plaquenil
Sulfasalazin medac
Proteinuria
Prednisolone
Polychemotherapy
Kidney

Feeds With Similar Papers

Inflammatory Bowel Disease

Inflammatory bowel diseases (IBD), Crohn’s disease and ulcerative colitis, arise due to chronic inflammation of the gastrointestinal tract. Here is the latest research.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

Oman Medical Journal

The Trends of DMARDS prescribed in Rheumatoid Arthritis Patients in Malaysia

Oman Medical JournalOctober 1, 2009
Wahinuddin SulaimanAnwar Arshad
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Download from

PubMed
/papers/renal-safety-of-initial-combination-versus-single/20346242